Comex 信息 以色列 30 - pharmaceutical products 3002 - 人体或动物制品
圖形 - 以色列 - 進口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 全年 FOB USD
-and-similar-products/WD-IL/1064/1/1/Fob/DepartureCountry-Date/All-Israel-Imports-1064-Year.png)
圖形 - 以色列 - 進口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 全年 FOB USD
-and-similar-products/WD-IL/1064/1/1/Fob/DepartureCountry-Date/All-Israel-Imports-1064-Year.png)
表 - 以色列 - 進口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 全年 FOB USD
|
Date
Export Countries
|
2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 美國 | 264.342.000 | 291.527.000 | 234.718.000 | 247.581.000 | 226.287.000 | 274.256.000 |
| 德國 | 260.981.000 | 217.620.000 | 222.496.000 | 187.956.000 | 191.172.000 | 163.050.000 |
| 瑞士 | 154.639.000 | 164.702.000 | 177.509.000 | 214.948.000 | 216.323.000 | 162.183.000 |
| 愛爾蘭 | 157.487.000 | 174.306.000 | 164.613.000 | 176.312.000 | 167.029.000 | 116.578.000 |
| 比利時 | 106.783.000 | 428.635.000 | 157.806.000 | 47.253.000 | 64.545.000 | 28.862.000 |
| 西班牙 | 17.855.000 | 80.678.000 | 85.216.000 | 121.884.000 | 95.459.000 | 11.284.000 |
| 法國 | 48.316.000 | 70.762.000 | 48.035.000 | 64.318.000 | 74.003.000 | 71.897.000 |
| 荷蘭 | 24.570.000 | 28.223.000 | 30.211.000 | 59.344.000 | 65.779.000 | 83.180.000 |
| 義大利 | 23.471.000 | 34.779.000 | 30.615.000 | 52.141.000 | 48.410.000 | 53.247.000 |
| 英國 | 28.961.000 | 24.771.000 | 29.839.000 | 42.388.000 | 46.470.000 | 41.059.000 |
| Others | 51.248.000 | 110.541.000 | 195.754.000 | 106.918.000 | 118.843.000 | 165.370.000 |
| Total | 1,138,653,000 | 1,626,544,000 | 1,376,812,000 | 1,321,043,000 | 1,314,320,000 | 1,170,966,000 |
圖形 - 以色列 - 進口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 每月 FOB USD
-and-similar-products/WD-IL/1064/1/4/Fob/DepartureCountry-Date/All-Israel-Imports-1064-Month.png)
圖形 - 以色列 - 進口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 每月 FOB USD
-and-similar-products/WD-IL/1064/1/4/Fob/DepartureCountry-Date/All-Israel-Imports-1064-Month.png)
表 - 以色列 - 進口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 每月 FOB USD
|
Date
Export Countries
|
05 - 2025 | 06 - 2025 | 07 - 2025 | 08 - 2025 | 09 - 2025 | 10 - 2025 |
|---|---|---|---|---|---|---|
| 美國 | 14.266.000 | 23.993.000 | 26.467.000 | 44.838.000 | 32.862.000 | 28.808.000 |
| 德國 | 13.904.000 | 24.968.000 | 16.103.000 | 8.884.000 | 18.076.000 | 22.336.000 |
| 瑞士 | 12.759.000 | 12.765.000 | 19.899.000 | 6.633.000 | 26.629.000 | 13.654.000 |
| 愛爾蘭 | 38.034.000 | 1.739.000 | 8.631.000 | 7.520.000 | 4.784.000 | 2.614.000 |
| 日本 | 3.624.000 | 8.822.000 | 10.491.000 | 8.337.000 | 226.000 | 8.955.000 |
| 法國 | 13.022.000 | 316.000 | 11.049.000 | 1.123.000 | 5.165.000 | 9.086.000 |
| 荷蘭 | 1.417.000 | 1.152.000 | 5.393.000 | 4.492.000 | 20.510.000 | 5.734.000 |
| 義大利 | 4.516.000 | 3.929.000 | 2.771.000 | 5.717.000 | 7.610.000 | 6.289.000 |
| 英國 | 3.303.000 | 6.055.000 | 5.609.000 | 4.532.000 | 2.445.000 | 5.042.000 |
| 立陶宛 | 5.331.000 | 2.776.000 | 2.742.000 | 2.048.000 | 4.832.000 | 4.567.000 |
| Others | 8.269.000 | 8.366.000 | 15.910.000 | 15.867.000 | 13.799.000 | 19.600.000 |
| Total | 118,445,000 | 94,881,000 | 125,065,000 | 109,991,000 | 136,938,000 | 126,685,000 |
圖形 - 以色列 - 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 全年 FOB USD
-and-similar-products/IL-WD/1064/2/1/Fob/DestinationCountry-Date/Israel-All-Exports-1064-Year.png)
圖形 - 以色列 - 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 全年 FOB USD
-and-similar-products/IL-WD/1064/2/1/Fob/DestinationCountry-Date/Israel-All-Exports-1064-Year.png)
表 - 以色列 - 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 全年 FOB USD
|
Date
Import Countries
|
2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 美國 | 141.878.000 | 78.362.000 | 76.932.000 | 106.470.000 | 188.354.000 | 168.025.000 |
| 巴西 | 5.819.000 | 4.974.000 | 6.156.000 | 24.594.000 | 21.133.000 | 38.387.000 |
| 俄羅斯 | 11.345.000 | 9.586.000 | 9.588.000 | 14.874.000 | 15.659.000 | 10.232.000 |
| 比利時 | 16.618.000 | 26.708.000 | 16.281.000 | 5.264.000 | 3.313.000 | 6.000 |
| 印度 | 6.443.000 | 10.532.000 | 8.420.000 | 12.443.000 | 14.710.000 | 9.671.000 |
| 德國 | 15.203.000 | 7.307.000 | 2.371.000 | 4.838.000 | 12.022.000 | 14.647.000 |
| 印尼 | 5.512.000 | 7.471.000 | 8.171.000 | 10.715.000 | 7.605.000 | 12.111.000 |
| 阿根廷 | 4.510.000 | 5.937.000 | 5.506.000 | 4.437.000 | 8.559.000 | 13.923.000 |
| 波蘭 | 4.335.000 | 5.538.000 | 8.266.000 | 7.110.000 | 7.270.000 | 4.026.000 |
| 義大利 | 18.000 | 87.000 | 38.000 | 13.830.000 | 7.214.000 | 6.425.000 |
| Others | 41.353.000 | 47.266.000 | 29.490.000 | 39.705.000 | 35.237.000 | 30.091.000 |
| Total | 253,034,000 | 203,768,000 | 171,219,000 | 244,280,000 | 321,076,000 | 307,544,000 |
圖形 - 以色列 - 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 每月 FOB USD
-and-similar-products/IL-WD/1064/2/4/Fob/DestinationCountry-Date/Israel-All-Exports-1064-Month.png)
圖形 - 以色列 - 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 每月 FOB USD
-and-similar-products/IL-WD/1064/2/4/Fob/DestinationCountry-Date/Israel-All-Exports-1064-Month.png)
表 - 以色列 - 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 每月 FOB USD
|
Date
Import Countries
|
05 - 2025 | 06 - 2025 | 07 - 2025 | 08 - 2025 | 09 - 2025 | 10 - 2025 |
|---|---|---|---|---|---|---|
| 美國 | 10.008.000 | 14.615.000 | 14.825.000 | 8.602.000 | 15.051.000 | 21.097.000 |
| 巴西 | 8.601.000 | 3.341.000 | 334.000 | 4.583.000 | 4.453.000 | 1.834.000 |
| 德國 | 574.000 | 1.097.000 | 894.000 | 4.749.000 | 1.483.000 | 2.163.000 |
| 阿根廷 | 4.248.000 | 16.000 | 5.142.000 | |||
| 印度 | 1.357.000 | 1.298.000 | 1.985.000 | 1.932.000 | 1.424.000 | 480.000 |
| 印尼 | 349.000 | 1.493.000 | 1.080.000 | 1.184.000 | 1.672.000 | 753.000 |
| 俄羅斯 | 1.156.000 | 1.229.000 | 1.776.000 | 1.976.000 | ||
| 義大利 | 1.458.000 | 293.000 | 704.000 | 569.000 | 932.000 | 409.000 |
| 加拿大 | 798.000 | 745.000 | 823.000 | |||
| 越南 | 586.000 | 147.000 | 392.000 | 226.000 | 435.000 | 566.000 |
| Others | 3.112.000 | 1.173.000 | 2.036.000 | 5.061.000 | 2.443.000 | 2.045.000 |
| Total | 31,449,000 | 23,473,000 | 23,479,000 | 29,480,000 | 35,756,000 | 30,170,000 |
圖形 - 以色列 - 進口 - 進化 / 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 全年 FOB USD
-and-similar-products/IL-IL/1064/3/1/Fob/-/Israel-Import-Export-1064-Year.png)
圖形 - 以色列 - 進口 - 進化 / 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 全年 FOB USD
-and-similar-products/IL-IL/1064/3/1/Fob/-/Israel-Import-Export-1064-Year.png)
表 - 以色列 - 進口 - 進化 / 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 全年 FOB USD
|
Date
Export Countries
|
2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Importaciones | ||||||
| 美國 | 264.342.000 | 291.527.000 | 234.718.000 | 247.581.000 | 226.287.000 | 274.256.000 |
| 德國 | 260.981.000 | 217.620.000 | 222.496.000 | 187.956.000 | 191.172.000 | 163.050.000 |
| 瑞士 | 154.639.000 | 164.702.000 | 177.509.000 | 214.948.000 | 216.323.000 | 162.183.000 |
| 愛爾蘭 | 157.487.000 | 174.306.000 | 164.613.000 | 176.312.000 | 167.029.000 | 116.578.000 |
| 比利時 | 106.783.000 | 428.635.000 | 157.806.000 | 47.253.000 | 64.545.000 | 28.862.000 |
| 西班牙 | 17.855.000 | 80.678.000 | 85.216.000 | 121.884.000 | 95.459.000 | 11.284.000 |
| 法國 | 48.316.000 | 70.762.000 | 48.035.000 | 64.318.000 | 74.003.000 | 71.897.000 |
| 荷蘭 | 24.570.000 | 28.223.000 | 30.211.000 | 59.344.000 | 65.779.000 | 83.180.000 |
| 義大利 | 23.471.000 | 34.779.000 | 30.615.000 | 52.141.000 | 48.410.000 | 53.247.000 |
| 英國 | 28.961.000 | 24.771.000 | 29.839.000 | 42.388.000 | 46.470.000 | 41.059.000 |
| Others | 51.248.000 | 110.541.000 | 195.754.000 | 106.918.000 | 118.843.000 | 165.370.000 |
| Total | 1,138,653,000 | 1,626,544,000 | 1,376,812,000 | 1,321,043,000 | 1,314,320,000 | 1,170,966,000 |
|
Date
Import Countries
|
2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Exportaciones | ||||||
| 美國 | 141.878.000 | 78.362.000 | 76.932.000 | 106.470.000 | 188.354.000 | 168.025.000 |
| 巴西 | 5.819.000 | 4.974.000 | 6.156.000 | 24.594.000 | 21.133.000 | 38.387.000 |
| 俄羅斯 | 11.345.000 | 9.586.000 | 9.588.000 | 14.874.000 | 15.659.000 | 10.232.000 |
| 比利時 | 16.618.000 | 26.708.000 | 16.281.000 | 5.264.000 | 3.313.000 | 6.000 |
| 印度 | 6.443.000 | 10.532.000 | 8.420.000 | 12.443.000 | 14.710.000 | 9.671.000 |
| 德國 | 15.203.000 | 7.307.000 | 2.371.000 | 4.838.000 | 12.022.000 | 14.647.000 |
| 印尼 | 5.512.000 | 7.471.000 | 8.171.000 | 10.715.000 | 7.605.000 | 12.111.000 |
| 阿根廷 | 4.510.000 | 5.937.000 | 5.506.000 | 4.437.000 | 8.559.000 | 13.923.000 |
| 波蘭 | 4.335.000 | 5.538.000 | 8.266.000 | 7.110.000 | 7.270.000 | 4.026.000 |
| 義大利 | 18.000 | 87.000 | 38.000 | 13.830.000 | 7.214.000 | 6.425.000 |
| Others | 41.353.000 | 47.266.000 | 29.490.000 | 39.705.000 | 35.237.000 | 30.091.000 |
| Total | 253,034,000 | 203,768,000 | 171,219,000 | 244,280,000 | 321,076,000 | 307,544,000 |
圖形 - 以色列 - 進口 - 進化 / 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 每月 FOB USD
-and-similar-products/IL-IL/1064/3/4/Fob/-/Israel-Import-Export-1064-Month.png)
圖形 - 以色列 - 進口 - 進化 / 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 每月 FOB USD
-and-similar-products/IL-IL/1064/3/4/Fob/-/Israel-Import-Export-1064-Month.png)
表 - 以色列 - 進口 - 進化 / 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 每月 FOB USD
|
Date
Export Countries
|
05 - 2025 | 06 - 2025 | 07 - 2025 | 08 - 2025 | 09 - 2025 | 10 - 2025 |
|---|---|---|---|---|---|---|
| Importaciones | ||||||
| 美國 | 14.266.000 | 23.993.000 | 26.467.000 | 44.838.000 | 32.862.000 | 28.808.000 |
| 德國 | 13.904.000 | 24.968.000 | 16.103.000 | 8.884.000 | 18.076.000 | 22.336.000 |
| 瑞士 | 12.759.000 | 12.765.000 | 19.899.000 | 6.633.000 | 26.629.000 | 13.654.000 |
| 愛爾蘭 | 38.034.000 | 1.739.000 | 8.631.000 | 7.520.000 | 4.784.000 | 2.614.000 |
| 日本 | 3.624.000 | 8.822.000 | 10.491.000 | 8.337.000 | 226.000 | 8.955.000 |
| 法國 | 13.022.000 | 316.000 | 11.049.000 | 1.123.000 | 5.165.000 | 9.086.000 |
| 荷蘭 | 1.417.000 | 1.152.000 | 5.393.000 | 4.492.000 | 20.510.000 | 5.734.000 |
| 義大利 | 4.516.000 | 3.929.000 | 2.771.000 | 5.717.000 | 7.610.000 | 6.289.000 |
| 英國 | 3.303.000 | 6.055.000 | 5.609.000 | 4.532.000 | 2.445.000 | 5.042.000 |
| 立陶宛 | 5.331.000 | 2.776.000 | 2.742.000 | 2.048.000 | 4.832.000 | 4.567.000 |
| Others | 8.269.000 | 8.366.000 | 15.910.000 | 15.867.000 | 13.799.000 | 19.600.000 |
| Total | 118,445,000 | 94,881,000 | 125,065,000 | 109,991,000 | 136,938,000 | 126,685,000 |
|
Date
Import Countries
|
05 - 2025 | 06 - 2025 | 07 - 2025 | 08 - 2025 | 09 - 2025 | 10 - 2025 |
|---|---|---|---|---|---|---|
| Exportaciones | ||||||
| 美國 | 10.008.000 | 14.615.000 | 14.825.000 | 8.602.000 | 15.051.000 | 21.097.000 |
| 巴西 | 8.601.000 | 3.341.000 | 334.000 | 4.583.000 | 4.453.000 | 1.834.000 |
| 德國 | 574.000 | 1.097.000 | 894.000 | 4.749.000 | 1.483.000 | 2.163.000 |
| 阿根廷 | 4.248.000 | 16.000 | 5.142.000 | |||
| 印度 | 1.357.000 | 1.298.000 | 1.985.000 | 1.932.000 | 1.424.000 | 480.000 |
| 印尼 | 349.000 | 1.493.000 | 1.080.000 | 1.184.000 | 1.672.000 | 753.000 |
| 俄羅斯 | 1.156.000 | 1.229.000 | 1.776.000 | 1.976.000 | ||
| 義大利 | 1.458.000 | 293.000 | 704.000 | 569.000 | 932.000 | 409.000 |
| 加拿大 | 798.000 | 745.000 | 823.000 | |||
| 越南 | 586.000 | 147.000 | 392.000 | 226.000 | 435.000 | 566.000 |
| Others | 3.112.000 | 1.173.000 | 2.036.000 | 5.061.000 | 2.443.000 | 2.045.000 |
| Total | 31,449,000 | 23,473,000 | 23,479,000 | 29,480,000 | 35,756,000 | 30,170,000 |
